Naftin

Naftin is a brand name of naftifine topical, approved by the FDA in the following formulation(s):

NAFTIN (naftifine hydrochloride - cream; topical)

• 
  Manufacturer: MERZ PHARMS
  
  Approval date: February 29, 1988
  
  Strength(s): 1% ^[RLD]


• 
  Manufacturer: MERZ PHARMS
  
  Approval date: January 13, 2012
  
  Strength(s): 2% ^[RLD]

NAFTIN (naftifine hydrochloride - gel; topical)

• 
  Manufacturer: MERZ PHARMS
  
  Approval date: June 18, 1990
  
  Strength(s): 1% ^[RLD]

Has a generic version of Naftin been approved?

No. There is currently no therapeutically equivalent version of Naftin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Naftin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Naftin.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • January 13, 2015 - NEW STRENGTH
  
  

See also...

• Naftin Cream Consumer Information (Wolters Kluwer)
• Naftin Gel Consumer Information (Wolters Kluwer)
• Naftin Consumer Information (Cerner Multum)
• Naftin Topical Advanced Consumer Information (Micromedex)
• Naftin AHFS DI Monographs (ASHP)
• Naftifine Cream Consumer Information (Wolters Kluwer)
• Naftifine Gel Consumer Information (Wolters Kluwer)
• Naftifine topical Consumer Information (Cerner Multum)
• Naftifine Topical Advanced Consumer Information (Micromedex)
• Naftifine Hydrochloride AHFS DI Monographs (ASHP)